Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.74932 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.71698 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7201 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.64969 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.65384 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.02334 | 41 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.7596 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.7042 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67604 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.69248 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.70194 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.68213 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.70697 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.70864 | 31 |